欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2006, Vol. 11 ›› Issue (4): 406-409.

• 研究原著 • 上一篇    下一篇

PMEA-Na在beagle犬血浆中的液相色谱/质谱/质谱联用法测定及其药代动力学

王文艳, 沈子龙, 汪师兵1, 姚全胜1   

  1. 中国药科大学生物技术中心, 南京210009, 江苏;
    1江苏省药物所药物安全评价中心, 南京210009, 江苏
  • 收稿日期:2005-12-23 接受日期:2006-03-14 出版日期:2006-04-26 发布日期:2020-12-08

Determination of PMEA-Na in dog plasma by liquid chromatography and tandem mass spectrometry and its pharmacokinetic study

WANG Wen-yan, SHEN Zi-long, WANG Shi-bing1, YAO Quan-sheng1   

  1. Center of Biotechnology, China Pharmaceutical University, Nanjing 210009, Jiangsu, China;
    1Jiangsu Province Center for Drug Safety Evaluation, Nanjing 210009, Jiangsu, China
  • Received:2005-12-23 Accepted:2006-03-14 Online:2006-04-26 Published:2020-12-08
  • Contact: YAO Quan-sheng, male, doctor director, researcher, engaged in toxi cology. Tel:025-83274013  E-mail:quanshengyao@163.com
  • About author:WANG Wen-yan, female, candidate PhD, specialized in toxicokinetics. Tel:13851997564  E-mail:wangwenyan345@yahoo.com.cn
  • Supported by:
    The project was supported by national 863 foundation of China(№2004AA2Z3776)

摘要: 目的:建立LC/MS/MS 法测定犬血浆中PMEA-Na 浓度, 进行其药代动力学研究。方法:血浆样品经甲醇沉淀蛋白后, 采用多反应监测法测定其血药浓度。色谱柱为Xterra MS 柱, 流动相为甲醇:水:甲酸(25:75:0.5), 流速为0.25 ml·min-1。Beagle 犬分3 个剂量组经静脉给药, 给药剂量分别为1.0 、3.0 和6.0 mg·kg-1。药代动力学参数通过DAS 软件计算获得。结果:PMEA-Na 线性范围:0.02~ 20 mg·L-1 (r = 0.999);最低检测浓度为20 μg·L-1, 方法回收率为97.1 %~ 107.3 %, 日内日间变异分别小于6.5 %、10.8 %。beagle 犬在1.0,3.0 与6.0 mg·kg-1剂量下单次iv PMEA-Na 后, 测得其AUC 分别为2.3 ±0.5, 8.2 ±1.3 and 18.5 ±1.3mg·L-1 ·h;t1/2 为3.9 ±1.8, 8.4 ±1.5 and 8.9 ±0.6 h;CL 为0.44 ±0.09, 0.35 ±0.05 and 0.31 ±0.03 ml·h-1 ·kg-1结论:本方法专属性强, 准确性好, 可用于PMEA-Na 血药浓度测定和药代动力学研究。

关键词: PMEA-Na, LC/MS/MS, 血药浓度, 药代动力学

Abstract: AIM: To established an HPLC/MS/MS method for the study of pharmcokinetics of PMEA-Na (the mono-sodium salts of 9-[2-(phosphonomethoxy) ethyl] adenine) in beagle dogs.METHODS: PMEA-Na and internal standard 9-(3-phosphony-methoxypropyl) adenine were isolated from plasma by protein precipitation with methanol, and then analyzed adopting multiple reaction monitoring (MRM) mode.Using Xterra MS column, the mobile phases consisted of methanol:water:formic acid (25:75:0.5) at a flow rate of 0.25 ml·min -1.Beagle dogs received the intravenous dosage of PMEA-Na at 1.0, 3.0 and 6.0 mg·kg -1.Pharmacokinetic parameters were obtained from concentration-time curves by non-linear least-squares regression using the program DAS.RESULTS: The linear calibration curve was obtained in the concentration range of 0.02 to 20 mg·L -1 (r =0.999), and the limit of quantitition was 20 μg·L -1.The withinday and internal-day precisions (RSD) were less than 6.5 % and 10.8 %, respectively.The accuracy was 97.1 %~ 107.3 %.After a single dose studies in dogs the AUC were 2.3 ±0.5, 8.2 ±1.3 and 18.5 ±1.3 mg·L -1·h;the t1/2 were 3.9 ±1.8, 8.4 ±1.5 and 8.9 ±0.6 h;the CL were 0.44 ±0.09, 0.35 ±0.05 and 0.31 ±0.03 ml·h -1 ·kg -1 at the dose level of 1.0, 3.0 and 6.0 mg·kg -1 respectively.CONCLUSION: The analytical method is sensitive and specific for investigation the pharmacokintics of PMEA-Na in beagle dogs.

Key words: PMEA-Na, LC/MS/MS, plasma concentration, pharmacokinetics

中图分类号: